GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ (NGS) NASDAQ (NGS) Primary 
XFRA Summary
GDRX Chart
People also search for
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope
GoodRx has rebounded from $2.50 per share, showing renewed growth momentum and improved consumer traction. New offerings have contributed to GDRX's recent positive developments, but the stock's rapid appreciation reflects these improvements. I remain marginally more positive, yet GDRX still presents considerable risk, warranting a continued neutral rating.
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
GoodRx Q2 Earnings Call Highlights
GoodRx NASDAQ: GDRX reported second-quarter 2026 revenue of $200.4 million and adjusted EBITDA of $63.7 million, representing a 31.8% adjusted EBITDA margin, as growth in its Pharma Direct and subscription businesses offset pressure in prescription transaction revenue.
GoodRx Holdings, Inc. Class A Common Stock Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 251 | $603.94 | $838.34 | $234.4 | 38.81% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 2,000 | $3,920 | $7,600 | $3,680 | 93.88% |
| NA Nizar Araji National Bank Of Canada /FI/ | 34,099 | $738,556.33 | $125,484.32 | -$613,072.01 | -83.01% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 68,202 | $133,675.92 | $250,983.36 | $117,307.44 | 87.76% |
| JM John Malone Amundi | 20,412 | $41,148.5 | $74,707.92 | $33,559.42 | 81.56% |
GoodRx Holdings, Inc. Class A Common Stock Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Glen Santangelo Barclays | -4,664.19 | $16,091.45 | $16,091.45 | - | - |
GoodRx Holdings, Inc. Class A Common Stock (GDRX) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has GoodRx Holdings, Inc. Class A Common Stock ever had a stock split?
GoodRx Holdings, Inc. Class A Common Stock Profile
| Health Care Technology Industry | Healthcare Sector | Wendy Barnes CEO | NASDAQ (NGS) Exchange | 38246G108 CUSIP |
| US Country | 697 Employees | - Last Dividend | - Last Split | 23 Sep 2020 IPO Date |
Overview
GoodRx Holdings, Inc. is an American healthcare company established in 2011, with its headquarters located in Santa Monica, California. It specializes in offering comprehensive information and tools designed to enable consumers in the United States to compare prices and save on prescription drug purchases. GoodRx operates by maintaining a sophisticated price comparison platform that not only provides consumers with accurate, geographically relevant prescription pricing information but also facilitates access to negotiated drug prices. Furthermore, the company caters to pharmacy benefit managers, who are instrumental in managing formularies and prescription transactions, including the determination of pricing between consumers and pharmacies.
Products and Services
GoodRx Holdings, Inc. provides a variety of healthcare products and services aimed at enhancing affordability and access to prescription medications and healthcare services:
- Price Comparison Platform: This core service enables consumers to compare prescription drug prices across various pharmacies in their area, ensuring they get the best available deal. It leverages curated, geographically relevant pricing data and provides access to specially negotiated drug prices.
- Subscriptions: GoodRx offers subscription services that allow consumers to access additional savings and benefits on prescription drugs, enhancing the value and convenience of their healthcare spending.
- Pharma Manufacturer Solutions: The company collaborates with pharmaceutical manufacturers to implement solutions that improve patient access to medications, including savings programs and other support initiatives designed to promote affordability.
- Telehealth Services (GoodRx Care): Expanding beyond prescription savings, GoodRx has ventured into telehealth through the GoodRx Care platform. This service provides consumers with convenient access to healthcare professionals for consultations, advice, and treatment planning, all from the comfort of their homes.
